Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00777647
Other study ID # 20070134B
Secondary ID
Status Completed
Phase N/A
First received October 21, 2008
Last updated March 28, 2017
Start date May 2008
Est. completion date December 2010

Study information

Verified date March 2017
Source Aarhus University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Compared to solid foods, the nutritional energy of drinks may bypass the appetite regulation leading to obesity development. Although drinks sweetened with aspartame are available the anticipated positive effect of these drinks on obesity development has not been convincing. However, the mechanisms linking drinks intake to obesity are yet to be clarified.

The investigators aim is to investigate the long-term effects of intake of soft drinks, milk and water. The study is a parallel, intervention trial with 80 overweight, healthy volunteers. They will be randomly selected to drink one liter a day of one of the four drinks for six months. The objectives are changes in numerous circulating metabolic risk factors, changes in body weight, anthropometric data and fat distribution (measured by DEXA, MRI and MR-spectroscopy).

The investigators expect to clarify the mechanisms linking drinking habits to obesity development and provide scientifically based nutritional guidelines.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date December 2010
Est. primary completion date December 2010
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 50 Years
Eligibility Inclusion Criteria:

- Age between 20-50 years;

- BMI between 28-36 kg/m2;

- Weight stabile 3 months prior to the study inclusion;

- Less than 10 hours of weekly exercise

Exclusion Criteria:

- Diabetes

- Allergic to phenylalanine or milk

- Smoking

- Pregnancy or breast-feeding

Study Design


Intervention

Other:
Sugar-sweetened soft drink
One litre a day for six months.
Aspartame-sweetened soft drink
One litre a day for six months.
Semi-skimmed milk
One litre a day for six months
Water
One litre a day for six months.

Locations

Country Name City State
Denmark Department of Internal Medicine/Endocrinology C, Aarhus University Hospital Aarhus

Sponsors (2)

Lead Sponsor Collaborator
Aarhus University Hospital LG Life Sciences

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Body Weight (kg) Six months
Primary MR spectroscopy to assess liver fat and skeletal muscle fat Six months
Primary Magnetic resonance imaging to assess visceral adipose tissue (VAT) and subcutaneous abdominal adipose tissue (SAAT) Six months
Primary Dual-energy X-ray absorptiometry (DEXA) scan to assess total fat mass (kg), lean body mass (kg), and bone mass (kg) Six months
Secondary Blood pressure Systolic and diastolic blood pressure (mmHg) Six months
Secondary Circulating metabolic parameters: including serum urate mmol/L Six months
Secondary fasting plasma glucose mmol/L Six months
Secondary fasting serum insulin pmol/L Six months
Secondary Oral Glucose Tolerance Test (OGTT) AUC OGTT glucose and insulin, AUC HOMA-IR, and Matzuda index Six months
Secondary Fasting blood lipids Total, LDL, and HDL cholesterol, and TAG (mmol/L) Six months
Secondary Fasting plasma FFA mmol/L Six months
Secondary Fasting plasma PAI-1 ng/ml Six months
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2